Clarus Therapeutics Holdings (CRXT) stock forecast for 2024. Forecast tables and graphs.







6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
Trading Penny Stocks for Profit: Expert Insights and Practical Advice

February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice

For aspiring traders and seasoned investors alike, the enticing appeal of penny stocks can be likened to voyaging across the vast oceans, discovering…
Getting A Kredittkort Norge Approval Isn’t Difficult

February 8, 2024 Getting A Kredittkort Norge Approval Isn’t Difficult

If you meet the conditions, you can open an account for checking in Norway. However, it will be much easier and more convenient…

Clarus Therapeutics Holdings (CRXT) stock forecast for 2024

Updated: March 18, 2024 (06:53)

Sector: Healthcare

The share price of Clarus Therapeutics Holdings, Inc. (CRXT) now

What analysts predict: $
52-week High/Low: $ / $

50/200 Day Moving Average: $ / $

This figure corresponds to the Average Price over the previous 50/200 days. For Clarus Therapeutics Holdings stocks, the 50-day moving average is the support level today.

For Clarus Therapeutics Holdings stocks, the 200-day moving average is the support level today.

Are you interested in Clarus Therapeutics Holdings, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Clarus Therapeutics Holdings stock price in 2024. How much will one Clarus Therapeutics Holdings share be worth in 2024? Is it worth taking profit / loss on CRXT stock now or waiting? What are analysts' forecasts for Clarus Therapeutics Holdings stock?

We forecast Clarus Therapeutics Holdings stock performance using neural networks based on historical data on CRXT stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

Clarus Therapeutics Holdings, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Clarus Therapeutics Holdings analysts is $. Today 200 Day Moving Average is the support level ( $). 50 Day Moving Average is the support level ( $).




Historical and forecast chart of Clarus Therapeutics Holdings, Inc. stock

The chart below shows the historical price of Clarus Therapeutics Holdings stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the CRXT stock price can be found in the table below.


Clarus Therapeutics Holdings, Inc. is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications. the company’s first commercial product is JATENZO. It is headquartered in Northbrook, IL.

Clarus Therapeutics Holdings (CRXT) Forecast for 2024

Month Target Pes. Opt. Vol., %
Apr 0.00 0.00 0.00 34.05 %
May 0.00 0.00 0.00 29.55 %
Jun 0.00 0.00 0.00 30.28 %
Jul 0.00 0.00 0.00 34.48 %
Aug 0.00 0.00 0.00 25.76 %
Sep 0.00 0.00 0.00 31.01 %
Oct 0.00 0.00 0.00 28.02 %
Nov 0.00 0.00 0.00 34.81 %
Dec 0.00 0.00 0.00 35.89 %

Clarus Therapeutics Holdings information and performance

Clarus Therapeutics Holdings Address

N/A

Market Capitalization: N/A $

Market capitalization of the Clarus Therapeutics Holdings, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CRXT shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of Clarus Therapeutics Holdings is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Clarus Therapeutics Holdings price target for 2024 by month


Target values for the price of one Clarus Therapeutics Holdings share for Apr 2024.

The weighted average target price per Clarus Therapeutics Holdings share in Apr 2024 is: 0.00.
In Apr, the Positive dynamics for Clarus Therapeutics Holdings, Inc. shares will prevail with possible monthly volatility of 34.046% volatility is expected.
Pessimistic target level: 0.00
Optimistic target level: 0.00

Target values for the price of one Clarus Therapeutics Holdings share for May 2024.

The weighted average target price per Clarus Therapeutics Holdings share in May 2024 is: 0.00.
In May, the Negative dynamics for Clarus Therapeutics Holdings, Inc. shares will prevail with possible monthly volatility of 29.549% volatility is expected.
Pessimistic target level: 0.00
Optimistic target level: 0.00

Target values for the price of one Clarus Therapeutics Holdings share for Jun 2024.

The weighted average target price per Clarus Therapeutics Holdings share in Jun 2024 is: 0.00.
In Jun, the Negative dynamics for Clarus Therapeutics Holdings, Inc. shares will prevail with possible monthly volatility of 30.285% volatility is expected.
Pessimistic target level: 0.00
Optimistic target level: 0.00

Target values for the price of one Clarus Therapeutics Holdings share for Jul 2024.

The weighted average target price per Clarus Therapeutics Holdings share in Jul 2024 is: 0.00.
In Jul, the Negative dynamics for Clarus Therapeutics Holdings, Inc. shares will prevail with possible monthly volatility of 34.480% volatility is expected.
Pessimistic target level: 0.00
Optimistic target level: 0.00

Target values for the price of one Clarus Therapeutics Holdings share for Aug 2024.

The weighted average target price per Clarus Therapeutics Holdings share in Aug 2024 is: 0.00.
In Aug, the Negative dynamics for Clarus Therapeutics Holdings, Inc. shares will prevail with possible monthly volatility of 25.759% volatility is expected.
Pessimistic target level: 0.00
Optimistic target level: 0.00

Target values for the price of one Clarus Therapeutics Holdings share for Sep 2024.

The weighted average target price per Clarus Therapeutics Holdings share in Sep 2024 is: 0.00.
In Sep, the Negative dynamics for Clarus Therapeutics Holdings, Inc. shares will prevail with possible monthly volatility of 31.007% volatility is expected.
Pessimistic target level: 0.00
Optimistic target level: 0.00

Target values for the price of one Clarus Therapeutics Holdings share for Oct 2024.

The weighted average target price per Clarus Therapeutics Holdings share in Oct 2024 is: 0.00.
In Oct, the Negative dynamics for Clarus Therapeutics Holdings, Inc. shares will prevail with possible monthly volatility of 28.018% volatility is expected.
Pessimistic target level: 0.00
Optimistic target level: 0.00

Target values for the price of one Clarus Therapeutics Holdings share for Nov 2024.

The weighted average target price per Clarus Therapeutics Holdings share in Nov 2024 is: 0.00.
In Nov, the Positive dynamics for Clarus Therapeutics Holdings, Inc. shares will prevail with possible monthly volatility of 34.808% volatility is expected.
Pessimistic target level: 0.00
Optimistic target level: 0.00

Target values for the price of one Clarus Therapeutics Holdings share for Dec 2024.

The weighted average target price per Clarus Therapeutics Holdings share in Dec 2024 is: 0.00.
In Dec, the Positive dynamics for Clarus Therapeutics Holdings, Inc. shares will prevail with possible monthly volatility of 35.893% volatility is expected.
Pessimistic target level: 0.00
Optimistic target level: 0.00



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.